In an inducible KRASG12D pancreatic cancer mouse model, the amplification and overexpression of the transcriptional coactivator Yap1 has been demonstrated to be a potential KRAS independent bypass mechanism (55). Here, KRAS is linked to familial pancreatic carcinoma.